Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Non-Opioid Pain Patch Industry?

In recent years, the market size of non-opioid pain patches has experienced steady growth. It is projected to expand from $3.48 billion in 2024 to $3.63 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%. The growth during the historic period can be credited to factors such as the rise in cases of chronic pain, patient inclination towards non-invasive therapies, advancements in formulations and ingredients, an increase in sports-related injuries, and worry over opioid addiction.

The market for non-opioid pain patches is projected to experience significant expansion in the coming years, reaching “$4.41 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. Factors contributing to growth during the forecast period are anticipated to include increased investment in research and development, a rise in healthcare spending, a favorable regulatory climate, heightened consumer awareness and education, as well as a growing aging population. The forecast period is expected to witness key trends such as the adoption of wireless and smart patch technologies, the implementation of natural ingredients, integration with wearable technology, the development of biodegradable and eco-friendly patches, and a concentration on longevity of effects.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12230&type=smp

What Forces Are Driving The Growth Of The Non-Opioid Pain Patch Industry?

The upward trend in chronic pain is projected to drive the growth of the non-opioid pain patch market in the future. Chronic pain is the term used for intense pain that persists for a long duration or occurs in conjunction with another health problem. Non-opioid pain patches, which are utilized to alleviate mild to moderate pain, are also effective in treating headaches, muscle aches, arthritis, backaches, and various other pain types. For instance, Eurostat, a governmental agency from Luxembourg, reported in November 2023 that over a third (36.1%) of the EU population reported suffering from a long-lasting health issue in 2022. As a result, the surge in chronic pain occurrences is fuelling the non-opioid pain patch market.

The non-opioid pain patch market covered in this report is segmented –

1) By Patch: Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patches

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

3) By Indication: Musculoskeletal Pain, Neuropathic Pain

Subsegments:

1) By Lidocaine Patches: 5% Lidocaine Patch, Other Concentrations

2) By Diclofenac Patches: 1.3% Diclofenac Patch, Other Concentrations

3) By Capsaicin Patches: 8% Capsaicin Patch, Other Concentrations

4) By Ketoprofen Patches: 5% Ketoprofen Patch, Other Concentrations

5) By Other Patches: Combination Patches, Herbal Extract Patches, Other Non-Opioid Patches

What Long-Term Trends Are Likely To Affect The Non-Opioid Pain Patch Market?

Product innovation is fast becoming a significant trend in the non-opioid pain patch market. Major firms in this market are striving to innovate their products to maintain their market dominance. For example, in June 2022, The Mentholatum Company Inc., a healthcare products producer in the UK, introduced Deep Relief Actiflex Patch, a pain relief patch containing no drugs. It is a cooling hydrogel patch filled with water, providing quick cooling and soothing relief as the water evaporates on the skin. This drug-free pain patch addresses muscle or joint aches and pains.

Who Are The Primary Players Operating Across The Global Non-Opioid Pain Patch Market?

Major companies operating in the non-opioid pain patch market include Hisamitsu Pharmaceutical Co., Inc., Teikoku Pharma USA, Inc., Purdue Pharma L.P., Noven Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Grünenthal GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Medtronic plc, Abbott Laboratories, Bayer AG, Iroko Pharmaceuticals, LLC, Scilex Pharmaceuticals Inc., Zosano Pharma Corporation, Adynxx Inc., BioElectronics Corporation, NeuroMetrix Inc., Virpax Pharmaceuticals Inc., Eli Lilly and Company, Novartis AG, Amgen Inc., DURECT Corporation

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

Which Region Offers The Most Growth Potential For The Non-Opioid Pain Patch Market Through 2029?

North America was the largest region in the non-opioid pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12230&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model